Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Hypertension patients not included exclusion criteria~* Mean seated SBP ≥140mmHg in patients with newly Diagnosed~Exclusion Criteria:~- msDBP≥110mmHg or ms SBP ≥ 180mmHg at the screening and randomization visit

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Losartan 50mg/amlodipine 5mg (Type: EXPERIMENTAL): Once daily, 1T, PO medication
- Losartan 100mg/amlodipine 5mg (Type: EXPERIMENTAL): Once daily, 1T, PO medication
- Losartan50 mg/Hydrochlorothiazide12.5 mg (Type: ACTIVE_COMPARATOR): Once daily, 1T, PO medication
- Losartan100 mg/Hydrochlorothiazide25 mg (Type: ACTIVE_COMPARATOR): Once daily, 1T, PO medication

Based on this trial design, predict the completion outcome and termination type (if applicable).